US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

2  3  4  5    7    9  10  11  
Five Prime Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Five Prime Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and ...  |  read more...
USD 350
Protein Kinase C Beta (PKC-Beta) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... of the report is to establish the understanding for all the pipeline drugs that fall under Protein Kinase C Beta (PKC-Beta) Inhibitors. This report provides information on the therapeutic development based on the Protein Kinase ...  |  read more...
USD 1,250
Dendritic Cell and CAR-T Therapies Market, 2014-2024
11/20/2014 | published by: Roots Analysis
... / orphan forms. Although oncology continues to be one of the most active areas in terms of drug development, there is still a significant unmet need. The focus of drug developers is gradually moving towards ...  |  read more...
USD 1,899
2014-2018 World Microbiology Market: Latest Instrumentation and Strategic Profiles of Leading Suppliers
11/11/2014 | published by: VPGMarketResearch.com
... and products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 86 pages Please note: The delivery time for the electronic version of this report ...  |  read more...
USD 3,500
Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... understanding for all the pipeline drugs that fall under Hematopoietic Stem Cell Transplantation. This report provides information on the therapeutic development based on the Hematopoietic Stem Cell Transplantation dealing with all the pipeline drugs, comparative ...  |  read more...
USD 1,250
Biotechnology Product Manufacturing
11/24/2014 | published by: First Research, Inc.
... Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), and Monsanto, as well as CSL (Australia), Merck KGaA (Germany), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). ...  |  read more...
USD 129
World: Case Materials - Market Report. Analysis and Forecast to 2020
11/17/2014 | published by: IndexBox Marketing Ltd.
... domestic production, exports and imports, price dynamics and trends in the industry. The report shows the sales data, allowing you to identify the key drivers and restraints. You can find here a strategic analysis of ...  |  read more...
USD 1,900
Anti-CD19 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD19 Antibody. This report provides information on the therapeutic development based on the Anti-CD19 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD28 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD28 Antibody. This report provides information on the therapeutic development based on the Anti-CD28 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD30 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD30 Antibody. This report provides information on the therapeutic development based on the Anti-CD30 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD33 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD33 Antibody. This report provides information on the therapeutic development based on the Anti-CD33 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD37 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD37 Antibody. This report provides information on the therapeutic development based on the Anti-CD37 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD70 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD70 Antibody. This report provides information on the therapeutic development based on the Anti-CD70 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Aurora A Kinase Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... to establish the understanding for all the pipeline drugs that fall under Aurora A Kinase Inhibitors. This report provides information on the therapeutic development based on the Aurora A Kinase Inhibitors dealing with mechanism of ...  |  read more...
USD 1,250
Biogen IDEC Inc (BIIB: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/29/2014 | published by: Plunkett Research, Ltd.
... compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Biogen IDEC Inc) includes growth forecast for its primary industry to the year 2021. The ...  |  read more...
USD 1,795
Amgen Inc (AMGN: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/28/2014 | published by: Plunkett Research, Ltd.
... its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Amgen Inc) includes growth forecast for its primary industry to the year 2021. The purpose of this ...  |  read more...
USD 1,795
Gilead Sciences Inc (GILD: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/28/2014 | published by: Plunkett Research, Ltd.
... compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Gilead Sciences Inc) includes growth forecast for its primary industry to the year 2021. The ...  |  read more...
USD 1,795
RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019
9/26/2014 | published by: MarketsandMarkets
... expected to grow at a CAGR of 13.7% during the forecast period of 2014 to 2019 and is estimated to be worth $3,773.0 million by 2019. The transcriptomics market has blatantly grown in the past ...  |  read more...
USD 4,650
Personalized Medicine Partnering Terms and Agreements
11/1/2014 | published by: Current Partnering
... to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter personalized medicine partnering deals. The ...  |  read more...
USD 3,295
Antibodies in Oncology: Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 125 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 278 drug targets that are included ...  |  read more...
USD 6,746
South Korea Tissue Engineered - Skin Substitutes Market Outlook to 2020
10/27/2014 | published by: GlobalData
... Tissue Engineered - Skin Substitutes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and ...  |  read more...
USD 2,500
Animal Feed Additives
11/1/2014 | published by: Global Industry Analysts
... for the US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market ...  |  read more...
USD 4,950
Biologicals in Oncology Drug Pipeline Update 2014
10/27/2014 | published by: BioSeeker Group AB
... developing 1784 biological drugs in 4104 developmental projects in cancer. In addition, there are 28 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 950 drugs. Biologicals In ...  |  read more...
USD 11,246
Cancer Stem Cells Drug Pipeline Update 2014
10/27/2014 | published by: BioSeeker Group AB
... development and cancer drugs which are inhibitors of the Hedgehog, Notch, and WNT Pathway. These developmental pathways are frequently activated in neoplasms, and particularly in the rare subpopulation of cancer stem cells. There are today ...  |  read more...
USD 6,746
Proteins in Oncology Drug Pipeline Update 2014
10/27/2014 | published by: BioSeeker Group AB
... 687 developmental projects in cancer. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 193 drugs. Proteins In Oncology Drug Pipeline Update lists ...  |  read more...
USD 6,746
2  3  4  5    7    9  10  11